PhD

Helen provides translational leadership to link drug discovery to unmet medical needs for Elixiron's immuno-oncology projects. Helen is an immunologist with research experience in the regulation of T cell exhaustion and innate immunity. She has published several peer-reviewed manuscripts in leading journals including Immunity and Journal of Immunology. Previously, Helen served as R&D Manager at Eusol Biotech where she was responsible for establishing immunological assays to support drug development.Prior to Eusol, she was a Research Fellow in the Protein Engineering Group at the Development Center for Biotechnology (DCB), Taiwan. There, she participated in preclinical development of biologic therapeutics. In addition to her former role in DCB, she held two research positions at Meridigen Biotech and UnicoCell Biomed. Helen earned her Ph.D. in Immunology from National Yang-Ming University and completed her postdoctoral training in the Institute of Molecular Biology at Academia Sinica.